专题：Cholangiocarcinoma and Gallbladder Cancer Studies

This cluster of papers focuses on the diagnosis, management, epidemiology, and therapeutic strategies for cholangiocarcinoma, including intrahepatic and hilar cholangiocarcinoma. It covers topics such as surgical management, molecular pathology, and prognostic factors. The papers also discuss the increasing incidence and mortality of biliary tract cancers, as well as emerging targeted therapies.
最新文献
Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation—Current Evidence and Future Directions

article Full Text OpenAlex

Liver transplantation for hepatocellular carcinoma: from patient selection and downstaging to risk stratification and post-transplant surveillance

article Full Text OpenAlex

Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study.

article Full Text OpenAlex

Clinical outcomes of pembrolizumab and enfortumab vedotin in variant histology urothelial carcinoma.

article Full Text OpenAlex

Galleri cancer tests: Controversial NHS trial fails to meet key goal

article Full Text OpenAlex

The role of transabdominal ultrasound in pancreatic cyst surveillance: correlation with cross-sectional imaging findings and malignancy risk

article Full Text OpenAlex

Evaluating the role of the main pancreatic duct in intraductal papillary mucinous neoplasm grading: A multi-structure radiomics-based machine learning approach

article Full Text OpenAlex

Outcome of resectable distal cholangiocarcinoma in a single-centre Western patient cohort: comparison of the 7th and 8th edition of the UICC/AJCC TNM classification

article Full Text OpenAlex

Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma

article Full Text OpenAlex

Impact of Additional Resection on Outcomes in Patients with Positive Proximal Margin of Perihilar Cholangiocarcinoma: A Systematic Review and Network Meta-analysis

article Full Text OpenAlex

近5年高被引文献
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer

article Full Text OpenAlex 1006 FWCI206.8703

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

article Full Text OpenAlex 922 FWCI296.1219

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

article Full Text OpenAlex 659 FWCI65.9229

Oral squamous cell carcinomas: state of the field and emerging directions

review Full Text OpenAlex 609 FWCI135.0267

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 562 FWCI114.0148

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

article Full Text OpenAlex 501 FWCI104.6341

Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma

article Full Text OpenAlex 480 FWCI154.1765

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

review Full Text OpenAlex 453 FWCI95.9146

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

article Full Text OpenAlex 374 FWCI77.6263

Gallbladder cancer

review Full Text OpenAlex 367 FWCI74.5565